These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28626480)

  • 1. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.
    Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S
    Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
    Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
    Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy.
    Emami J; Pourmashhadi A; Sadeghi H; Varshosaz J; Hamishehkar H
    Pharm Dev Technol; 2015 Nov; 20(7):791-800. PubMed ID: 24841045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
    Rattanupatam T; Srichana T
    Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
    Wang Y; Kho K; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
    Alkholief M; Kalam MA; Anwer MK; Alshamsan A
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD.
    Mohamed A; Pekoz AY; Ross K; Hutcheon GA; Saleem IY
    Int J Pharm; 2019 Oct; 569():118524. PubMed ID: 31319144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate.
    Shiehzadeh F; Tafaghodi M; Dehghani ML; Mashhoori F; Fazly Bazzaz BS; Imenshahidi M
    Adv Pharm Bull; 2019 Jun; 9(2):255-261. PubMed ID: 31380251
    [No Abstract]   [Full Text] [Related]  

  • 13. Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
    Almutairi M; Hefnawy A; Almotairy A; Alobaida A; Alyahya M; Althobaiti A; Adel Ali Youssef A; Elkanayati RM; Ashour EA; Smyth HDC; Repka MA
    Int J Pharm; 2024 Apr; 655():124044. PubMed ID: 38527563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
    Sham JO; Zhang Y; Finlay WH; Roa WH; Löbenberg R
    Int J Pharm; 2004 Jan; 269(2):457-67. PubMed ID: 14706257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen Delivery.
    Scherließ R; Janke J
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis.
    Ahmed S; Mansour M; Ishak RAH; Mortada ND
    Int J Pharm; 2023 Jul; 642():123117. PubMed ID: 37315636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.
    Kunda NK; Alfagih IM; Dennison SR; Tawfeek HM; Somavarapu S; Hutcheon GA; Saleem IY
    Pharm Res; 2015 Apr; 32(4):1341-53. PubMed ID: 25297713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.